A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of italian multiple osteochrondromas patients

Emanuela Signori, Emanuela Massi, Maria Giovanna Matera, Monica Poscente, Carolina Gravina, Gianluca Falcone, Michele Attilio Rosa, Monica Rinaldi, Wim Wuyts, Davide Seripa, Bruno Dallapiccola, Vito Michele Fazio

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Multiple osteochondromas (MO), also known as hereditary multiple exostoses (HME), is one of the most common hereditary musculoskeletal diseases in Caucasians (1/50,000) with wide clinical variability and genetic heterogeneity. Two genes have thus far been identified as causing the disease, namely EXT1 and EXT2. Various methods to detect mutations in the EXT genes have been used. Here a cohort of 100 MO patients belonging to unrelated Italian families have been analyzed by single-strand conformation polymorphism (SSCP) analysis or by denaturing high performance liquid chromatography (DHPLC). However, neither of these techniques can detect deletions or duplications of entire exons. Families that were negative at SSCP/DHPLC analysis underwent two-color multiple ligation-dependent probe amplification (MLPA) analysis. By these complementary techniques mutation detection was significantly improved and 26 novel mutations have been revealed as well as 18 previously described mutations to give a total of 44 different mutations. Thus we can conclude that combining MLPA with DHPLC in point-mutations negative MO families, the detection of mutations in EXT genes can significantly improve the identification of both point-mutations and mid-size rearrangements. More important, we were able to characterize all those patients who were negative at the first PCR-based method screening.

Original languageEnglish
Pages (from-to)470-477
Number of pages8
JournalGenes Chromosomes and Cancer
Volume46
Issue number5
DOIs
Publication statusPublished - May 2007

Fingerprint

Multiple Hereditary Exostoses
Mutation
Genes
High Pressure Liquid Chromatography
Point Mutation
Ligation
Musculoskeletal Diseases
Inborn Genetic Diseases
Genetic Heterogeneity
Exons
Color
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of italian multiple osteochrondromas patients. / Signori, Emanuela; Massi, Emanuela; Matera, Maria Giovanna; Poscente, Monica; Gravina, Carolina; Falcone, Gianluca; Rosa, Michele Attilio; Rinaldi, Monica; Wuyts, Wim; Seripa, Davide; Dallapiccola, Bruno; Fazio, Vito Michele.

In: Genes Chromosomes and Cancer, Vol. 46, No. 5, 05.2007, p. 470-477.

Research output: Contribution to journalArticle

Signori, Emanuela ; Massi, Emanuela ; Matera, Maria Giovanna ; Poscente, Monica ; Gravina, Carolina ; Falcone, Gianluca ; Rosa, Michele Attilio ; Rinaldi, Monica ; Wuyts, Wim ; Seripa, Davide ; Dallapiccola, Bruno ; Fazio, Vito Michele. / A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of italian multiple osteochrondromas patients. In: Genes Chromosomes and Cancer. 2007 ; Vol. 46, No. 5. pp. 470-477.
@article{77d92d53577e4c53b439380637e07e4c,
title = "A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of italian multiple osteochrondromas patients",
abstract = "Multiple osteochondromas (MO), also known as hereditary multiple exostoses (HME), is one of the most common hereditary musculoskeletal diseases in Caucasians (1/50,000) with wide clinical variability and genetic heterogeneity. Two genes have thus far been identified as causing the disease, namely EXT1 and EXT2. Various methods to detect mutations in the EXT genes have been used. Here a cohort of 100 MO patients belonging to unrelated Italian families have been analyzed by single-strand conformation polymorphism (SSCP) analysis or by denaturing high performance liquid chromatography (DHPLC). However, neither of these techniques can detect deletions or duplications of entire exons. Families that were negative at SSCP/DHPLC analysis underwent two-color multiple ligation-dependent probe amplification (MLPA) analysis. By these complementary techniques mutation detection was significantly improved and 26 novel mutations have been revealed as well as 18 previously described mutations to give a total of 44 different mutations. Thus we can conclude that combining MLPA with DHPLC in point-mutations negative MO families, the detection of mutations in EXT genes can significantly improve the identification of both point-mutations and mid-size rearrangements. More important, we were able to characterize all those patients who were negative at the first PCR-based method screening.",
author = "Emanuela Signori and Emanuela Massi and Matera, {Maria Giovanna} and Monica Poscente and Carolina Gravina and Gianluca Falcone and Rosa, {Michele Attilio} and Monica Rinaldi and Wim Wuyts and Davide Seripa and Bruno Dallapiccola and Fazio, {Vito Michele}",
year = "2007",
month = "5",
doi = "10.1002/gcc.20429",
language = "English",
volume = "46",
pages = "470--477",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of italian multiple osteochrondromas patients

AU - Signori, Emanuela

AU - Massi, Emanuela

AU - Matera, Maria Giovanna

AU - Poscente, Monica

AU - Gravina, Carolina

AU - Falcone, Gianluca

AU - Rosa, Michele Attilio

AU - Rinaldi, Monica

AU - Wuyts, Wim

AU - Seripa, Davide

AU - Dallapiccola, Bruno

AU - Fazio, Vito Michele

PY - 2007/5

Y1 - 2007/5

N2 - Multiple osteochondromas (MO), also known as hereditary multiple exostoses (HME), is one of the most common hereditary musculoskeletal diseases in Caucasians (1/50,000) with wide clinical variability and genetic heterogeneity. Two genes have thus far been identified as causing the disease, namely EXT1 and EXT2. Various methods to detect mutations in the EXT genes have been used. Here a cohort of 100 MO patients belonging to unrelated Italian families have been analyzed by single-strand conformation polymorphism (SSCP) analysis or by denaturing high performance liquid chromatography (DHPLC). However, neither of these techniques can detect deletions or duplications of entire exons. Families that were negative at SSCP/DHPLC analysis underwent two-color multiple ligation-dependent probe amplification (MLPA) analysis. By these complementary techniques mutation detection was significantly improved and 26 novel mutations have been revealed as well as 18 previously described mutations to give a total of 44 different mutations. Thus we can conclude that combining MLPA with DHPLC in point-mutations negative MO families, the detection of mutations in EXT genes can significantly improve the identification of both point-mutations and mid-size rearrangements. More important, we were able to characterize all those patients who were negative at the first PCR-based method screening.

AB - Multiple osteochondromas (MO), also known as hereditary multiple exostoses (HME), is one of the most common hereditary musculoskeletal diseases in Caucasians (1/50,000) with wide clinical variability and genetic heterogeneity. Two genes have thus far been identified as causing the disease, namely EXT1 and EXT2. Various methods to detect mutations in the EXT genes have been used. Here a cohort of 100 MO patients belonging to unrelated Italian families have been analyzed by single-strand conformation polymorphism (SSCP) analysis or by denaturing high performance liquid chromatography (DHPLC). However, neither of these techniques can detect deletions or duplications of entire exons. Families that were negative at SSCP/DHPLC analysis underwent two-color multiple ligation-dependent probe amplification (MLPA) analysis. By these complementary techniques mutation detection was significantly improved and 26 novel mutations have been revealed as well as 18 previously described mutations to give a total of 44 different mutations. Thus we can conclude that combining MLPA with DHPLC in point-mutations negative MO families, the detection of mutations in EXT genes can significantly improve the identification of both point-mutations and mid-size rearrangements. More important, we were able to characterize all those patients who were negative at the first PCR-based method screening.

UR - http://www.scopus.com/inward/record.url?scp=33947378729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947378729&partnerID=8YFLogxK

U2 - 10.1002/gcc.20429

DO - 10.1002/gcc.20429

M3 - Article

C2 - 17301954

AN - SCOPUS:33947378729

VL - 46

SP - 470

EP - 477

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 5

ER -